Received Mar 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
did not received her second dose within the recommended period; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose of shingrix on an unknown date). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: did not received her second dose within the recommended period). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date : 04-MAR-2025 The pharmacist mentioned that they did not have date of birth or initials for the patient, and they did not know date of administration, lot number or expiration date for the first dose. They did not know if the first dose was administered at their facility. Till the time of reporting, the patient did not receive 2nd dose of Shingrix within the recommended period, which led to incomplete course of vaccination. This case was linked with US2021AMR128772, US2020221334 and US2020019136, reported by same reporter.; Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR128772:same reporter US-GSK-US2020221334:same reporter US-GLAXOSMITHKLINE-US2020019136:same reporter